1. Home
  2. NTRB vs ICG Comparison

NTRB vs ICG Comparison

Compare NTRB & ICG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRB
  • ICG
  • Stock Information
  • Founded
  • NTRB 2016
  • ICG 2017
  • Country
  • NTRB United States
  • ICG China
  • Employees
  • NTRB N/A
  • ICG N/A
  • Industry
  • NTRB Industrial Specialties
  • ICG Semiconductors
  • Sector
  • NTRB Health Care
  • ICG Technology
  • Exchange
  • NTRB Nasdaq
  • ICG Nasdaq
  • Market Cap
  • NTRB 71.7M
  • ICG 67.3M
  • IPO Year
  • NTRB N/A
  • ICG 2023
  • Fundamental
  • Price
  • NTRB $6.05
  • ICG $1.04
  • Analyst Decision
  • NTRB Buy
  • ICG Strong Buy
  • Analyst Count
  • NTRB 1
  • ICG 1
  • Target Price
  • NTRB $13.00
  • ICG $7.50
  • AVG Volume (30 Days)
  • NTRB 42.3K
  • ICG 184.0K
  • Earning Date
  • NTRB 12-03-2025
  • ICG 11-13-2025
  • Dividend Yield
  • NTRB N/A
  • ICG N/A
  • EPS Growth
  • NTRB N/A
  • ICG N/A
  • EPS
  • NTRB N/A
  • ICG 0.05
  • Revenue
  • NTRB $2,578,059.00
  • ICG $43,282,895.00
  • Revenue This Year
  • NTRB $560.75
  • ICG N/A
  • Revenue Next Year
  • NTRB $588.39
  • ICG $64.55
  • P/E Ratio
  • NTRB N/A
  • ICG $21.97
  • Revenue Growth
  • NTRB 42.92
  • ICG 63.55
  • 52 Week Low
  • NTRB $2.98
  • ICG $0.94
  • 52 Week High
  • NTRB $9.42
  • ICG $12.04
  • Technical
  • Relative Strength Index (RSI)
  • NTRB 37.35
  • ICG 30.12
  • Support Level
  • NTRB $5.55
  • ICG $0.94
  • Resistance Level
  • NTRB $6.99
  • ICG $1.13
  • Average True Range (ATR)
  • NTRB 0.47
  • ICG 0.13
  • MACD
  • NTRB -0.09
  • ICG 0.00
  • Stochastic Oscillator
  • NTRB 11.87
  • ICG 16.53

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

About ICG Intchains Group Limited

Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.

Share on Social Networks: